Suitability of liposomal carriers for systemic delivery of risedronate using the pulmonary route
Nasr, Maha; Taha, Ismail; Hathout, Rania M;
Abstract
This study aims at testing the hypothesis that reversed phase evaporation liposomes (REVs) are suitable for systemic delivery of an anti-osteporotic drug (risedronate sodium (RS)) via pulmonary nebulization.
Other data
| Title | Suitability of liposomal carriers for systemic delivery of risedronate using the pulmonary route | Authors | Nasr, Maha ; Taha, Ismail; Hathout, Rania M | Issue Date | Nov-2013 | Journal | Drug delivery | Volume | 20 | Issue | 8 | Start page | 311 | End page | 318 | ISSN | 1071-7544 1521-0464 |
DOI | 10.3109/10717544.2013.835160 | PubMed ID | 24079347 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.